The FORCE Blog
Posts 225 to 238 of 350
September 12, 2018
Starting a Conversation about My Family Health History
Posted in:
Books And Movies
Tags:
BRCA ,
Genetic Counseling ,
Genetic Testing ,
Inherited Cancer
September 07, 2018
Volunteer Spotlight - Sandra Dei Dolori
Posted in:
Volunteer Spotlight
Tags:
FORCE ,
Volunteer
August 27, 2018
FORCE Co-Authors Paper on Engaging Patient Advocates in Research
Posted in:
Research
Tags:
Clinical Trials ,
Patient Advocacy ,
Patient Engagement ,
Cancer Research ,
Research Advocacy ,
Patient Centered Research
August 16, 2018
Book Blog: The Bucket List
Posted in:
Books And Movies
Tags:
BRCA1 ,
Risk-reducing Mastectomy
June 17, 2018
Solving for Y: Reaching Men About Genetic Testing for Hereditary Breast, Ovarian, Pancreatic, Prostate And Related Cancers (HBOC)
Posted in:
Men With Mutations ,
Genetic Testing
Tags:
BRCA ,
Hereditary Cancer ,
Breast Cancer ,
Cancer Prevention ,
Genetic Counseling ,
Genetic Testing ,
BRCA1 ,
BRCA2 ,
Previvor ,
HBOC ,
Prostate Cancer ,
USPSTF ,
Screening And Prevention ,
PALB2 ,
PTEN ,
Pancreatic Cancer ,
Male Breast Cancer ,
CHEK2 ,
ATM
June 14, 2018
Me and My MSH6 Mutation: Ever Searching for Answers
Posted in:
XRAY ,
Stories
Tags:
BRCA ,
Genetic Counseling ,
Genetic Testing ,
Lynch Syndrome ,
Breast Cancer Risk ,
MSH6
May 01, 2018
Volunteer Spotlight - Elana Fata
Posted in:
Volunteer Spotlight
Tags:
FORCE ,
Volunteer
April 27, 2018
The Lights of May
Posted in:
Inspirational
Tags:
Hereditary Cancer ,
Breast Cancer ,
Prophylactic Mastectomy ,
BRCA1 ,
BRCA2 ,
Prophylactic Surgery ,
Survivor ,
Oophorectomy ,
Talking To Children
April 23, 2018
One More Reason Hoda Kotb is My Hero
Posted in:
Supporting FORCE
Tags:
Supporting Force ,
Cause Marketing
April 12, 2018
PARP Inhibitors and Hereditary Cancer: What’s New?
Posted in:
Research ,
Cancer Treatment
Tags:
BRCA ,
Ovarian Cancer ,
Genetic Testing ,
BRCA1 ,
BRCA2 ,
PALB2 ,
Pancreatic Cancer ,
ATM ,
Gene Panel Testing ,
Metastatic Breast Cancer ,
Ovarian Cancer Treatment ,
PARP Inhibitor ,
Cancer Research ,
Advanced Breast Cancer ,
Inherited Mutations ,
Prostate Cancer Treatment ,
Metastatic Prostate Cancer ,
Cancer Targeted Therapy